How is a challenge test different from a standard antimicrobial efficacy test?

A challenge test specifically evaluates a finished formulation's own preservative system by deliberately inoculating the product with defined microorganisms and monitoring the population decline over an extended period (typically up to 28 days), rather than testing a single active ingredient's kill rate in isolation — it validates the product as it will actually be manufactured and sold.

At what time points is a challenge test typically sampled?

Standard protocols (such as USP and ISO 11930) sample the microbial population at defined intervals after inoculation — commonly at day 0 (baseline), then at intermediate points such as 7 and 14 days, and a final point at 28 days — to track the rate and extent of microbial reduction over the product's realistic in-use timeframe.

What organisms are used to inoculate the product in a challenge test?

Standard panels include representative bacteria (such as Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa) and fungi (such as Candida albicans and Aspergillus brasiliensis), inoculated separately at defined starting concentrations to challenge the preservative system against the range of organisms it needs to control.

Do pass/fail criteria differ between pharmaceutical and cosmetic products?

Yes — USP (pharmaceutical) and ISO 11930 (cosmetic) define different acceptance criteria and product categories (such as injectable vs. topical, or leave-on vs. rinse-off), with more stringent log-reduction and time requirements for higher-risk product categories.

Why does a formulation need a challenge test if its individual preservatives already passed antimicrobial efficacy testing?

An individual preservative's raw antimicrobial activity can be reduced once incorporated into a finished formulation — through binding to other ingredients, pH shifts, partitioning into an oil phase, or dilution — so the challenge test validates the preservative system's real-world performance within the specific matrix, not just the preservative's activity in isolation.

CHALLENGE-TEST

Challenge Test (Teste de Desafio)

Teste de eficácia de conservantes através de contaminação intencional segundo USP <51>, EP 5.1.3 e ISO 11930 para validação de sistemas de preservação.

Solicitar relatório →← Voltar à antimicrobial microbiology

O que é CHALLENGE-TEST

Uma técnica de análise avançada

Teste de eficácia de conservantes através de contaminação intencional segundo USP <51>, EP 5.1.3 e ISO 11930 para validação de sistemas de preservação.

SensibilidadeAlta

Estado da amostraVariável

私たちの違い

スペクトルだけをお渡しすることはありません。お渡しするのは解釈です。

どの検査機関でもピークと数値は返せます。私たちの報告書はデータを読み解きます。私たちが提供する価値を決定づける3つの違いを、匿名化した実際の事例で以下にご紹介します。

複数の分析技術を、1つの統合された報告書に

バラバラの5つの報告書をお渡しすることはありません。すべての分析技術の結果を突き合わせ、各シグナルを他と照合したうえで、単一の解釈にまとめ上げます — データの山ではなく、答えにたどり着くためです。

汚染調査 — 異物の由来を特定し追跡する。
性能劣化 — ロットが想定外の挙動を示す理由を説明する。
新規サプライヤーの検証 — 切り替え前に同等性を証明する。

分析結果の収束・実際の事例1つが不一致：NMR

FTIR赤外分光法

同等

FTラマンラマン散乱

同等

XRDX線回折

同等

XRF蛍光X線分析

同等

固体¹³C NMR核磁気共鳴・固体状態

差異を検出

LDPE 3ロット · 4技術が一致し、NMRのみが差異を明らかに

4. 実験的根拠

半結晶性ポリマー系では、加工時の熱力学的変数が鎖のコンフォメーション動態に影響します¹。固体NMRはナノメートルスケールの化学的環境を分解でき²、XRDやFTIRでは検出できない変化にも感度を示します³。

参考文献

1Muller et al. (2015). Polymer Testing, 45, 112–120.

2Schmidt-Rohr & Spiess (1994). Multidimensional Solid-State NMR.

3Korbi et al. (2025). J. Appl. Polym. Sci., 142, e5531.

文献に裏付けられた技術的根拠

報告書における技術選択と推論はすべて、査読済み文献に基づき、本文中に引用を明記しています。結論は単なる意見ではなく、監査でもお客様への説明でも通用する、追跡可能な論拠です。

主張と出典を結びつける番号付き引用
分析対象ごとに参照される公式規格・方法
最初から最後まで検証可能な論理展開

結論と専門家の見解

報告書は主任研究員が署名する明確な見解で締めくくられます — データが示すこと、まだ断定できないこと、そして次のステップです。推論の限界についても正直に注記しており、これが単なる推測と技術的見解を分けるポイントです。

結果だけでなく明確な技術的見解を提示
推論の限界を正直に明記
主任研究員(P.I.)署名による次のステップの提案

8. 結論

4つの技術が同等性を確認しましたが、 固体NMRのみ が、従来のQCでは判別できない微妙なコンフォメーション変化を明らかにしました — これはろ過挙動の異常と一致する分子シグネチャです。

工業ラインのパラメータがないため、直接的な因果関係は特定できません — 解明のための追加調査を推奨します。

Dr. ██████████主任研究員 · CRQ 381965

署名済み

Aplicações de mercado

Onde a CHALLENGE-TEST entrega resultados

Aplicações de mercado

ファーマ

Preservative efficacy testing (USP <51>)
Validation of non-sterile formulations
Antimicrobial effectiveness testing
Preservation system development
Preservative quality control

材料

Biocide efficacy in materials
Resistance to microbial contamination
Polymer preservation validation
Microbial degradation testing
Biofilm control assessment

化粧品

Mandatory challenge test (ISO 11930)
Validation of preservative blends
Deliberate contamination of finished products
Formulation development support
Microbiological quality control

FAQ

Frequently Asked Questions about Challenge Testing

How is a challenge test different from a standard antimicrobial efficacy test?: A challenge test specifically evaluates a finished formulation's own preservative system by deliberately inoculating the product with defined microorganisms and monitoring the population decline over an extended period (typically up to 28 days), rather than testing a single active ingredient's kill rate in isolation — it validates the product as it will actually be manufactured and sold.
At what time points is a challenge test typically sampled?: Standard protocols (such as USP <51> and ISO 11930) sample the microbial population at defined intervals after inoculation — commonly at day 0 (baseline), then at intermediate points such as 7 and 14 days, and a final point at 28 days — to track the rate and extent of microbial reduction over the product's realistic in-use timeframe.
What organisms are used to inoculate the product in a challenge test?: Standard panels include representative bacteria (such as Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa) and fungi (such as Candida albicans and Aspergillus brasiliensis), inoculated separately at defined starting concentrations to challenge the preservative system against the range of organisms it needs to control.
Do pass/fail criteria differ between pharmaceutical and cosmetic products?: Yes — USP <51> (pharmaceutical) and ISO 11930 (cosmetic) define different acceptance criteria and product categories (such as injectable vs. topical, or leave-on vs. rinse-off), with more stringent log-reduction and time requirements for higher-risk product categories.
Why does a formulation need a challenge test if its individual preservatives already passed antimicrobial efficacy testing?: An individual preservative's raw antimicrobial activity can be reduced once incorporated into a finished formulation — through binding to other ingredients, pH shifts, partitioning into an oil phase, or dilution — so the challenge test validates the preservative system's real-world performance within the specific matrix, not just the preservative's activity in isolation.

Vamos conversar

Precisa de uma análise por CHALLENGE-TEST?

Compartilhe seu desafio analítico e a nossa equipe define o método, o preparo de amostra e o escopo do relatório.

Solicitar orçamento →